Literature DB >> 3115888

Chromosomal resistance of gonococci to antibiotics.

C A Ison1, J Gedney, C S Easmon.   

Abstract

Three hundred and twenty nine strains of non-penicillinase-producing Neisseria gonorrhoeae (non-PPNG) isolated from men and women were tested for their susceptibility to a range of antibiotics, and were also auxotyped and serogrouped. Nearly 6% (18) of 312 strains tested were resistant to 1 mg/l or more penicillin (compared with 4.4% of PPNG strains isolated in 1981). Many (198, 64%) strains showed intermediate resistance to penicillin (0.12-0.5 mg/l). Nearly 5% (15) of 312 strains tested were resistant to 0.5 mg/l or more cefuroxime, and there was a high degree of cross resistance between these two antibiotics. High levels of resistance to erythromycin and tetracycline were also found, and there was also appreciable cross resistance between these antibiotics and the beta lactam drugs. Resistance to spectinomycin was rare, and there was no cross resistance between spectinomycin and other agents tested. Levels of resistance between strains isolated from different anatomical sites did not differ, except that resistance to erythromycin was greater in rectal isolates. Four main auxotypes were detected. Strains requiring arginine, hypoxanthine, and uracil (AHU-) were more prevalent from the cervix. We have shown that there is an association between auxotype, serogroup, and level of sensitivity to penicillin, cefuroxime, and tetracycline.

Entities:  

Mesh:

Substances:

Year:  1987        PMID: 3115888      PMCID: PMC1194075          DOI: 10.1136/sti.63.4.239

Source DB:  PubMed          Journal:  Genitourin Med        ISSN: 0266-4348


  20 in total

1.  Penicillinase producing gonococci: a spent force?

Authors:  C A Ison; J Gedney; J R Harris; C S Easmon
Journal:  Genitourin Med       Date:  1986-10

2.  Chromosomally mediated resistance in Neisseria gonorrhoeae in the United States: results of surveillance and reporting, 1983-1984.

Authors:  R J Rice; J W Biddle; Y A JeanLouis; W E DeWitt; J H Blount; S A Morse
Journal:  J Infect Dis       Date:  1986-02       Impact factor: 5.226

3.  Nutritional profiles of Neisseria gonorrhoeae, Neisseria meningitidis, and Neisseria lactamica in chemically defined media and the use of growth requirements for gonococcal typing.

Authors:  B W Catlin
Journal:  J Infect Dis       Date:  1973-08       Impact factor: 5.226

4.  Inheritance of low-level resistance to penicillin, tetracycline, and chloramphenicol in Neisseria gonorrhoeae.

Authors:  P F Sparling; F A Sarubbi; E Blackman
Journal:  J Bacteriol       Date:  1975-11       Impact factor: 3.490

5.  Genetic analysis of drug resistance in Neisseria gonorrhoeae: identification and linkage relationships of loci controlling drug resistance.

Authors:  T W Maier; L Zubrzycki; M B Coyle
Journal:  Antimicrob Agents Chemother       Date:  1975-05       Impact factor: 5.191

6.  Penicillinase-producing Neisseria gonorrhoeae.

Authors:  W A Ashford; R G Golash; V G Hemming
Journal:  Lancet       Date:  1976-09-25       Impact factor: 79.321

7.  Beta-lactamase-producing, penicillin-resistant gonococcus.

Authors:  I Phillips
Journal:  Lancet       Date:  1976-09-25       Impact factor: 79.321

8.  Serogrouping Neisseria gonorrhoeae: correlation of coagglutination serogroup WII with homosexually acquired infection.

Authors:  K G Reid; H Young
Journal:  Br J Vener Dis       Date:  1984-10

9.  Spectinomycin as initial treatment for gonorrhoea.

Authors:  C S Easmon; G E Forster; G D Walker; C A Ison; J R Harris; P E Munday
Journal:  Br Med J (Clin Res Ed)       Date:  1984-10-20

10.  Novel method for detection of beta-lactamases by using a chromogenic cephalosporin substrate.

Authors:  C H O'Callaghan; A Morris; S M Kirby; A H Shingler
Journal:  Antimicrob Agents Chemother       Date:  1972-04       Impact factor: 5.191

View more
  13 in total

1.  Outbreak of cefozopran (penicillin, oral cephems, and aztreonam)-resistant Neisseria gonorrhoeae in Japan.

Authors:  T Muratani; S Akasaka; T Kobayashi; Y Yamada; H Inatomi; K Takahashi; T Matsumoto
Journal:  Antimicrob Agents Chemother       Date:  2001-12       Impact factor: 5.191

2.  Concordance of auxotype/serovar classes of Neisseria gonorrhoeae between sexual contacts.

Authors:  C A Ison; L Whitaker; A Renton
Journal:  Epidemiol Infect       Date:  1992-10       Impact factor: 2.451

Review 3.  Beta-lactamase plasmids and chromosomally mediated antibiotic resistance in pathogenic Neisseria species.

Authors:  J A Dillon; K H Yeung
Journal:  Clin Microbiol Rev       Date:  1989-04       Impact factor: 26.132

4.  Sampling methods for monitoring changes in gonococcal populations.

Authors:  K M Bindayna; C A Ison
Journal:  Epidemiol Infect       Date:  1989-08       Impact factor: 2.451

5.  Epidemiology of penicillin resistant Neisseria gonorrhoeae.

Authors:  C A Ison; C S Easmon
Journal:  Genitourin Med       Date:  1991-08

6.  Associations between serotype and susceptibility to antibiotics of Neisseria gonorrhoeae.

Authors:  N Woodford; K M Bindayna; C S Easmon; C A Ison
Journal:  Genitourin Med       Date:  1989-04

7.  In vitro activity of eight antimicrobial agents against non-penicillinase-producing gonococci isolated in Munich.

Authors:  D Abeck; A P Johnson; F Alexander; H C Korting; R C Ballard
Journal:  Genitourin Med       Date:  1988-08

8.  Antimicrobial susceptibilities and serotyping of Neisseria gonorrhoeae in southern Africa: influence of geographical source of infection.

Authors:  C A Ison; N S Roope; Y Dangor; F Radebe; R Ballard
Journal:  Epidemiol Infect       Date:  1993-04       Impact factor: 2.451

9.  Antibiotic susceptibilities, serotypes and auxotypes of Neisseria gonorrhoeae isolated in New Zealand.

Authors:  M S Brett; H G Davies; J R Blockley; H M Heffernan
Journal:  Genitourin Med       Date:  1992-10

10.  Neisseria gonorrhoeae isolated at St. Mary's Hospital London, 1980-91.

Authors:  A M Renton; C A Ison; L Whitaker; K Kirtland; E Kupek; J R Harris
Journal:  Genitourin Med       Date:  1993-08
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.